KfH Kuratorium für Dialyse und Nierentransplantation e.V.

Industry / private company


Location: Neu-Isenburg u.a., Germany (DE) DE

ISNI: -

ROR: https://ror.org/03rmqr166

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials (2025) Lee MM, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JF, et al. Journal article Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6 (2025) Apperloo EM, Cherney DZ, Kuhlman AB, Mann JF, Rasmussen S, Rossing P, Tuttle KR, et al. Journal article Management of systemic lupus erythematosus—Including secondary antiphospholipid syndrome, fertility and pregnancy: S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2 Management des systemischen Lupus erythematodes – inklusive sekundärem Antiphospholipidsyndrom, Kinderwunsch und Schwangerschaft: S3-Leitlinie der Deutschen Gesellschaft für Rheumatologie und Klinische Immunologie e. V. und Deutsche Gesellschaft für Neurologie e. V. (DGN), Deutsche Gesellschaft für Innere Medizin e. V. (DGIM), Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), Gesellschaft für Thrombose und Hämostaseforschung e. V. (GTH), Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e. V. (DGHO), Deutsche Gesellschaft für Kinder- und Jugendmedizin e. V. (DGKJ), Gesellschaft für Kinder- und Jugendrheumatologie e. V. (GKJR), Deutsche Gesellschaft für Nephrologie e. V. (DGfN), Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP), Deutsche Rheuma-Liga Bundesverband e. V., Lupus Erythematodes Selbsthilfegemeinschaft e. V., Deutsche Dermatologische Gesellschaft e. V. (DDG). Version: 1.2 (2025) Mucke J, Anders HJ, Aringer M, Berlit P, Böltz S, Burchardi FC, Dörner T, et al. Journal article, Review article Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials (2025) Badve SV, Bilal A, Lee MM, Sattar N, Gerstein HC, Ruff CT, McMurray JJ, et al. Journal article Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (2024) Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JF, Bakris G, Baeres FM, et al. Journal article Spot urinary sodium in CKD patients: correlation with 24h-excretion and evaluation of commonly used prediction equations (2024) Kurzhagen J, Titze S, Büschges-Seraphin B, Schiffer M, Schneider M, Eckardt KU, Hilgers KF Journal article Modification of Dialysate Na+ Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na+ Deposition in Patients on Hemodialysis. (2024) Kopp C, Kittler L, Linz P, Kannenkeril D, Horn S, Chazot C, Schiffer M, et al. Journal article Differentiating primary and secondary FSGS using non-invasive urine biomarkers. (2024) Catanese L, Siwy J, Wendt R, Amann KU, Beige J, Hendry B, Mischak H, et al. Journal article Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial (2023) McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JF, Marx N, Mulvagh SL, et al. Journal article International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action (2023) Cheung AK, Whelton PK, Muntner P, Schutte AE, Moran AE, Williams B, Sarafidis P, et al. Journal article
1 2 3